Skip to main
LNTH

Lantheus Holdings (LNTH) Stock Forecast & Price Target

Lantheus Holdings (LNTH) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 43%
Buy 43%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Lantheus Holdings is well positioned to continue its growth trajectory with its strong portfolio of precision diagnostics and radiopharmaceuticals, as well as its strategic partnerships. The recent retirement of the CEO has not had a significant impact on the company's operations, and the incoming CEO will have a solid foundation to build upon with a diversified set of products and a stable financial outlook. Additionally, with the recent approval of Pylarify and upcoming catalysts, such as the transition to TruVu and potential for future product approvals and partnerships, Lantheus Holdings has the potential for strong revenue and profit growth in the coming years.

Bears say

Lantheus Holdings is heavily dependent on the success and sustained use of its leading products, DEFINITY and PYLARIFY, which currently make up over 80% of total sales. However, with increased competition in the marketplace and the potential for major disruptions to the company's commercial footprint and manufacturing capabilities, there are significant risks to continued growth and stability. Additionally, reductions in coverage and reimbursement from third-party payors could significantly impact demand for the company's products.

Lantheus Holdings (LNTH) has been analyzed by 7 analysts, with a consensus rating of Buy. 43% of analysts recommend a Strong Buy, 43% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Lantheus Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Lantheus Holdings (LNTH) Forecast

Analysts have given Lantheus Holdings (LNTH) a Buy based on their latest research and market trends.

According to 7 analysts, Lantheus Holdings (LNTH) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Lantheus Holdings (LNTH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.